|
|||||
|
|
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma |
|
| Authors: | Cristina Pérez Julia González-Rincón Arantza Onaindia Carmen Almaráz Nuria García-Díaz Helena Pisonero Soraya Curiel-Olmo Sagrario Gómez Laura Cereceda Rebeca Madureira Mercedes Hospital Dolores Suárez-Massa José L. Rodriguez-Peralto Concepción Postigo Alicia Leon-Castillo Carmen González-Vela Nerea Martinez Pablo Ortiz-Romero Margarita Sánchez-Beato Miguel á. Piris José P. Vaqué |
| Abstract: | |
| Keywords: | JAK mutations CTCL ruxolitinib JAK/STAT targeted therapy molecular diagnostics |